1）石原聡一郎，飯沼久恵，福島慶久，他：直腸癌に対する術前化学放射線療法の効果予測：臨床病理因子の解析と末梢血リンパ球を用いた実験的検討．癌の臨59，2013（印刷中）
2）Shin US, Yu CS, Kim JH, et al：Mucinous rectal cancer：effectiveness of preoperative chemoradiotherapy and prognosis. Ann Surg Oncol 18：2232-2329, 2011
3）Das P, Skibber JM, Rodriguez-Bigas MA, et al：Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109：1750-1755, 2007
4）Yoon SM, Kim DY, Kim TH, et al：Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 69：1167-1172, 2007
5）Fu CG, Tominaga O, Nagawa H, et al：Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 41：68-74, 1998
6）Chang HJ, Jung KH, Kim DY, et al：Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Hum Pathol 36：364-371, 2005
7）Kobayashi H, Hashiguchi Y, Ueno H, et al：Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy. Dis Colon Rectum 50：1354-1362, 2007
8）Kim NK, Park JK, Lee KY, et al：p53, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancer. Ann Surg Oncol 8：418-424, 2001
9）Shinto E, Hashiguchi Y, Ueno H, et al：Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients. Dis Colon Rectum 54：1098-1106, 2011
10）Watanabe T, Komuro Y, Kiyomatsu T, et al：Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66：3370-3374, 2006
11）Kitayama J, Yasuda K, Kawai K, et al：Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiation oncology 5：47, 2010
12）Ishihara S, Iinuma H, Fukushima Y, et al：Radiation-induced apoptosis of peripheral blood lymphocytes is correlated with histological regression of rectal cancer in response to preoperative chemoradiotherapy. Ann Surg Oncol 19：1192-1198, 2012
13）Ishihara S, Watanabe T, Kiyomatsu T, et al：Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer. Int J Colorectal Dis 25：1417-1425, 2010
14）Topova L, Hellmich G, Puffer E, et al：Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma. Dis Colon Rectum 54：401-411, 2011
15）Yeo SG, Kim DY, Park JW, et al：Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 82：e193-199, 2012
16）Yeung JM, Kalff V, Hicks RJ, et al：Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome. Dis Colon Rectum 54：518-525, 2011
17）Kim CW, Yu CS, Yang SS, et al：Clinical significance of pre-to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 18：3271-3277, 2011
18）Ishihara S, Watanabe T, Akahane T, et al：Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer. Int J Colorectal Dis 26：911-917, 2011
19）Stintzing S：Hand-foot-syndrome（HFS）is a clinical predictor of survival in Capecitabine treated with colorectal cancer. ESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, 2012
20）Ishihara S, Akahane T, Horiuchi A, et al：Neutrophil ratio in peripheral white blood cells is a prognostic factor in rectal cancer patients treated with preoperative chemoradiotherapy and total mesorectal excision. Hepatogastroenterology（in press）
ログイン
ランキング
お知らせ
ログイン
